Association of combination statin and antihypertensive therapy with reduced Alzheimer's disease and related dementia risk.

PloS One
Douglas BartholdJulie Zissimopoulos

Abstract

Hyperlipidemia and hypertension are modifiable risk factors for Alzheimer's disease and related dementias (ADRD). Approximately 25% of adults over age 65 use both antihypertensives (AHTs) and statins for these conditions. While a growing body of evidence found statins and AHTs are independently associated with lower ADRD risk, no evidence exists on simultaneous use for different drug class combinations and ADRD risk. Our primary objective was to compare ADRD risk associated with concurrent use of different combinations of statins and antihypertensives. In a retrospective cohort study (2007-2014), we analyzed 694,672 Medicare beneficiaries in the United States (2,017,786 person-years) who concurrently used both statins and AHTs. Using logistic regression adjusting for age, socioeconomic status and comorbidities, we quantified incident ADRD diagnosis associated with concurrent use of different statin molecules (atorvastatin, pravastatin, rosuvastatin, and simvastatin) and AHT drug classes (two renin-angiotensin system (RAS)-acting AHTs, angiotensin converting enzyme inhibitors (ACEIs) or angiotensin-II receptor blockers (ARBs), vs non-RAS-acting AHTs). Pravastatin or rosuvastatin combined with RAS-acting AHTs reduce risk of ADRD ...Continue Reading

References

Nov 23, 2000·Lancet·H JickD A Drachman
Oct 5, 2001·The American Journal of Medicine·P H ChongC Franklin
Sep 5, 2002·Journal of Clinical Pharmacology·C Michael White
Sep 6, 2002·Journal of Molecular Neuroscience : MN·Suzana S PetanceskaLorenzo M Refolo
Aug 18, 2004·Circulation·Carl J Vaughan, Antonio M Gotto
Jan 31, 2006·The American Journal of Cardiology·Keith C FerdinandUNKNOWN ARIES Study Group
Mar 17, 2007·Lancet Neurology·Patrick G Kehoe, Gordon K Wilcock
Oct 22, 2008·Journal of Neurology, Neurosurgery, and Psychiatry·M D M HaagM M B Breteler
Mar 27, 2009·Journal of the Neurological Sciences·Nagaendran Kandiah, Howard H Feldman
Oct 3, 2009·Trends in Neurosciences·Patrick G KehoeSeth Love
Jun 11, 2010·Journal of the American Geriatrics Society·Ge LiEric B Larson
Oct 18, 2011·Journal of Neuropathology and Experimental Neurology·James Scott MinersSeth Love
Nov 16, 2011·Archives of Neurology·Nina E ShepardsonDennis J Selkoe
Feb 1, 2012·Expert Opinion on Drug Metabolism & Toxicology·Joseph McGraw, Donald Waller
Mar 24, 2012·Clinical Medicine Insights. Cardiology·Ahai LuvaiJulian H Barth
Apr 5, 2013·Journal of Hypertension·Natacha Levi MarpillatPatrick Maison
Nov 20, 2013·Annals of Internal Medicine·Karl RichardsonEmil M deGoma
Jan 1, 2014·JAMA Neurology·Bruce ReedWilliam Jagust
Sep 22, 2015·Journal of the American Geriatrics Society·Whitney WhartonIhab Hajjar
Nov 1, 2014·Forum for Health Economics & Policy·Julie ZissimopoulosPatricia St Clair
Feb 19, 2017·Alzheimer's Research & Therapy·Nophar GeifmanAtul J Butte
Jul 25, 2017·Lancet·Gill LivingstonNaaheed Mukadam
Feb 24, 2018·Neurology. Genetics·Andréa L BenedetUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Mar 7, 2018·Translational Neurodegeneration·Bob G SchultzDaniel J Berlau
Apr 19, 2018·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·Julie M ZissimopoulosEileen M Crimmins
Oct 27, 2018·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Cynthia Chen, Julie M Zissimopoulos
Nov 15, 2018·The New England Journal of Medicine·Patricia Neuman, Gretchen A Jacobson

❮ Previous
Next ❯

Citations

Oct 24, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Virginia BorroniFrancisco J Barrantes
Sep 22, 2020·Pharmacology & Therapeutics·Jason D Vadhan, Robert C Speth
Dec 31, 2020·Antioxidants·Cadiele Oliana ReichertSergio P Bydlowski
Oct 30, 2020·Frontiers in Neuroscience·Caglar CosardereliogluPeter M Abadir
Oct 23, 2020·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Johanna ThunellJulie Zissimopoulos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.